Click For Photo: https://amp.businessinsider.com/images/5b43794945aaf52b008b4ae7-750-375.jpg
Research published in The Lancet shows promising results from an experimental HIV vaccine.
The vaccine generated robust immune responses against HIV in healthy adults.
Step - Vaccine - Risk - Women - Southern
The next step is to give the vaccine to 2600 "at risk" women in Southern Africa.
According to research recently published in the Lancet, researchers have made an important breakthrough towards developing a vaccine to protect against HIV.
Attempts - Virus - Vaccines
Most attempts have failed because the virus is able to rapidly mutate, making most vaccines ineffective.
However, scientists in the US have created a vaccine that has managed to get to the first step, with almost 400 healthy uninfected adults mounting an immune response to the vaccine.
Trial - Adults - Clinics - East - Africa
The trial recruited 393 HIV-uninfected adults aged 18 to 50 from clinics in east Africa, South Africa, Thailand and the US.
The Mosaic HIV vaccine is one of only five experimental vaccines to make it this far since the HIV/AIDS...
Wake Up To Breaking News!